CANCER IMMUNOTHERAPY INDEX

The Loncar Cancer Immunotherapy Index seeks to track the combined performance of a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become a foundational treatment for cancer over the next ten years.  The index will provide a metric to follow its progress as researchers advance new technologies for the benefit of courageous patients who fight the disease.  It is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

Screen Shot 2021-06-17 at 3.44.20 PM.png
Screen Shot 2021-06-17 at 5.05.27 PM.png
Screen Shot 2021-06-17 at 5.06.47 PM.png

Latest Quote

Index Constituents

Click on a name to learn more about its immunotherapy program

Screen Shot 2021-06-17 at 3.45.12 PM.png

Prices delayed up to 15 min

regeneron-regn-logo.png
logo-49.png
21-12-Ymabs-logo-2016.jpg
image2-2.jpg
rHqnvszj_400x400.png
200px-Zymeworks_Logo.svg.png
KR6D6PeA.jpeg
vM5vzXvw.png
0mrFDT2w.jpeg
nuWloqwg.jpeg
6bwGew6A.png
yPcL9Gyw.png
IMAB-Logo.png
NASDAQ_ATRA.png
logo-ALX-Oncology-Apr18_color.jpg
Genmab.jpg
Rubius_Logo.jpg
Shattuck Labs.png
InstilBio.png
ImmunityBio.png

Loncar Investments, LLC : P.O Box 15072, Lenexa, KS  66285 : 913-871-5007 : Not investment advice or a solicitation to buy or sell securities